The FDA's new head has been accused of being too close to industry. Here, he tells Jeanne Lenzer why partnership with the private sector is vital Robert Califf, the new commissioner of the US Food and Drug Administration, is on a mission: he wants to streamline medical research and to ...
Doctor David Kessler, who ran the FDA from 1990 to 1997, doesn't hold back when talking about theexplosion in opioiduse in the last two decades. "This has been one of the great mistakes of modern medicine," said Kessler, who went on to sayopioid addictionin the U.S....
Head of FDA food division resigns Jim Jones, deputy commissioner for human foods, resigned Monday following what he called the "indiscriminate firing" of roughly 89 people, according to sources familiar with the matter. February 19, 2025 Additional Live Streams Live ABC News Live Live View of ...
The same contraceptive became a political liability under Hamburg when the FDA attempted to approve its sale over-the-counter for teenagers. But at the eleventh hour the head of the department of Health and Human Services intervened and overruled FDA, deciding that young girls shouldn't be able ...
Taking over the leadership of FDA is a little like jumping into a rushing river. You're not starting from scratch on virtually any issue, and instead you join dozens of important developments already in progress. What's worse, most of them are controversial. Actually, it's like jumping into...
FDA’s Patrizia CavazzoniFDA ByLizzy LawrenceandAdam Feuerstein Jan. 10, 2025 Patrizia Cavazzoni, leader of the Food and Drug Administration’s Center for Drug Evaluation and Research, is leaving the agency on Jan. 18, the latest top official to exit as Donald Trump prepares to take office. ...
Hollister which handles health and science issues, said the high-level meet-up was anything but ordinary. McAndrew speculates Apple may either be looking for ways to clear regulatory hurdles ahead of a medical device or app launch, or is trying to push something through the FDA a...
When the US Food and Drug Administration (FDA) approved biotechnology firm Biogen’s drug for Alzheimer’s disease in June, regulators hoped to usher in a new era of treatment for the neurodegenerative condition. But the decision followed an independent advisory committee’s near-unanimous vote to...
An interview with Dr. Dan Schultz, Director of FDA's CDRH: it has been one year since Dr. Dan Schultz became the head of the Center for Devices and Radiological Health. This month's "View From The Top" takes a look at his first 12 months and finds out what is on his agenda for ...
On December 12, the Senate confirmed the appointment of Stephen Hahn, MD, as the new commissioner of the Food and Drug Administration (FDA). Hahn has been the chief medical executive at MD Anderson Cancer Center in Houston since 2018 and head of the division of radiation oncology since 2015...